|
|||||
       |
(geneva.usmission.gov) Researchers at University of Liverpool in the U.K. are developing nanoscale therapies to treat HIV and AIDS, and collaborating with a company to take the drugs to market. The project is funded by a £1.65 million ($US 2.61 million) grant from the U.K.’s Engineering and Physical Sciences Research Council. The aim of . . . → Read More: University to Develop, Commercialize HIV/AIDS Nanomedicines  One comment - (Comments are closed)  Finance, Joint ventures/collaborations, New products  biomedical, clinical trials, Europe, grant, HIV, life sciences, nanotechnology, pharmaceuticals, U.K., university Brandon Marshall (Brown University) A Brown University epidemiologist developed a computer simulation that can model the spread of HIV in New York City, under various scenarios of interventions. Brandon Marshall (pictured left) discusses his work in two sessions at this week’s International AIDS Society Conference in Washington, D.C. The model creates a community . . . → Read More: Computer Simulation Models Effects of HIV Policies One comment - (Comments are closed) New products, Regulations biomedical, computer science, HIV, mathematics, pharmaceuticals, software, university David Margolis (Univ of North Carolina in Chapel Hill) A team led by researchers at University of North Carolina in Chapel Hill have found a drug given to fight lymphoma was able to dislodge heretofore hidden virus in patients with HIV. The findings appear online in this week’s issue of the journal Nature . . . → Read More: Lymphoma Drug Found to Uncover Dormant HIV One comment - (Comments are closed) Joint ventures/collaborations, New products biomedical, clinical trials, HIV, life sciences, NIH, pharmaceuticals, university (geneva.usmission.gov) A $1.1 million grant from the National Research Council of Canada will fund research and development at University of British Columbia and iCo Therapeutics Inc. in Vancouver, B.C. to reformulate an existing drug into a therapy to fight HIV infection. The company iCo Therapeutics specializes in redosing or reformulating current drugs into . . . → Read More: Grant to Fund Drug Reformulation for HIV Therapy 2 comments - (Comments are closed) Finance, Intellectual property biomedical, Canada, grant, HIV, licensing, life sciences, pharmaceuticals, university Women at a health clinic in Haiti (State.gov) Research by global health investigators and cancer specialists suggests that aspirin should be evaluated for its ability to prevent development of cervical cancer in HIV-infected women. The findings by a team from New York-Presbyterian Hospital and Weill Cornell Medical Center in New York, with colleagues . . . → Read More: Aspirin Could Help Prevent Cervical Cancer in Women with HIV One comment - (Comments are closed) New products biomedical, cancer, HIV, life sciences, pharmaceuticals, university Chil-Yong Kang (University of Western Ontario) A vaccine designed to prevent HIV infection based on a genetically engineered virus has received approval by the U.S. Food and Drug Administration to start clinical trials. The vaccine is a product of a joint venture between Universiy of Western Onatrio in London and the Canadian subsidiary . . . → Read More: Engineered HIV/AIDS Vaccine Approved for Clinical Trials One comment - (Comments are closed) Joint ventures/collaborations, Regulations Asia, biomedical, Canada, clinical trials, FDA, HIV, Korea, life sciences, patent, pharmaceuticals, university (geneva.usmission.gov) A report by Pharmaceutical Research and Manufacturers of America (PhRMA) says U.S. biopharmaceutical companies are testing 88 medicines and vaccines to treat or prevent HIV/AIDS and related conditions. The report, issued on World AIDS Day (1 December 2011), also lists 36 currently approved medications for HIV infection and AIDS. According to PhRMA’s . . . → Read More: PhRMA: 88 HIV/AIDS Meds in Development at U.S. Companies One comment - (Comments are closed) New products biomedical, clinical trials, FDA, HIV, life sciences, pharmaceuticals (fnal.gov) CytoDyn Inc., a biotechnology company in Lutz, Florida, has agreed to support research by Spripps Research Institute scientist John Elder on the company’s treatment for feline immunodeficiency virus (FIV). Elder is a professor in Scripps’s Department of Immunology and Microbial Science in La Jolla, California. Under the agreement CytoDyn’s subsidiary, CytoDyn Veterinary . . . → Read More: Scripps, Biotech to Partner on Feline Virus Research Comments are closed Joint ventures/collaborations biomedical, biotechnology, grant, HIV, life sciences, patent, pharmaceuticals (Research.gov) The National Institute of Allergy and Infectious Diseases (NIAID) of National Institutes of Health awarded three research teams more than $14 million a year, for up to five years, to develop strategies to help rid the body of HIV infections. The grants to project teams composed of private companies and universities or . . . → Read More: Company-Institute Teams to Tackle Residual HIV Infection One comment - (Comments are closed) Finance, Joint ventures/collaborations biomedical, biotechnology, grant, HIV, life sciences, NIH, pharmaceuticals, university (A. Kotok) Bloomberg News reports that the Supreme Court ruled today in favor of the Swiss pharmaceutical company Roche, against a suit filed by Stanford University in Palo Alto, California that contended Roche violated the university’s patent rights under the 1980 Bayh-Dole Act. The 7-2 vote affirmed a lower court decision that Roche . . . → Read More: Court Rules for Companies in University Collaborations One comment - (Comments are closed) Intellectual property, Joint ventures/collaborations economics, grant, HIV, life sciences, medical device, NIH, patent, university |
||||
|
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
RSS - Posts
You must be logged in to post a comment.